AbeBeta;4578041 said:
Just pointing out that if we "dominated" the market you would expect us to have far more of the big companies. This also speaks directly to the arguments about who is paying to produce the medicines. You would think if the original argument were correct that England and Germany would have massively high drug costs because they have more of the big companies per capita
The European countries that are required to do their own FDA-type trials
do have high non-generic drug prices; the consumer just doesn't usually have to pay them, since it's part of each individual's national healthcare policy. Mind you, the use of name-brand drugs is restricted under that system, such that specific diagnoses and documentation must be present in order for the patient to be supplied a non-generic drug. You can always pay retail price (outside of the system), but most would not choose to do that because of the cost.
All prescription drugs sold in the US (regardless of the company's corporate location) must go through the FDA approval process, which as I previously mentioned, is meticulous and expensive. And wouldn't you want it to be exhaustive? Wouldn't we all want to assure that approved drugs are the safest possible, with all potential complications elicited?